UM

Browse/Search Results:  1-10 of 16 Help

Selected(0)Clear Items/Page:    Sort:
Elevating the acceptable cost threshold for solid oxide cells: A case study on refinery decarbonization Journal article
Chi, Yingtian, Lin, Jin, Li, Peiyang, Yu, Zhipeng, Mu, Shujun, Li, Xi, Song, Yonghua. Elevating the acceptable cost threshold for solid oxide cells: A case study on refinery decarbonization[J]. Applied Energy, 2024, 373, 123829.
Authors:  Chi, Yingtian;  Lin, Jin;  Li, Peiyang;  Yu, Zhipeng;  Mu, Shujun; et al.
Favorite | TC[WOS]:1 TC[Scopus]:1  IF:10.1/10.4 | Submit date:2024/08/05
Acceptable Cost Threshold  Ammonia  Cost Effectiveness  Long-duration Energy Storage  Refinery Decarbonization  Solid Oxide Cell  
Pharmacoeconomic evaluation of anti-obesity drugs for chronic weight management: a systematic review of literature Journal article
Xue, Yan, Zou, Huimin, Ruan, Zhen, Chen, Xianwen, Lai, Yunfeng, Yao, Dongning, Ung, Carolina Oi Lam, Hu, Hao. Pharmacoeconomic evaluation of anti-obesity drugs for chronic weight management: a systematic review of literature[J]. Frontiers in Endocrinology, 2023, 14, 1254398.
Authors:  Xue, Yan;  Zou, Huimin;  Ruan, Zhen;  Chen, Xianwen;  Lai, Yunfeng; et al.
Favorite | TC[WOS]:1 TC[Scopus]:1  IF:3.9/4.9 | Submit date:2024/02/22
Anti-obesity Drugs  Cost-effectiveness  Methodology  Modeling  Obesity  
Optimizing waste activated sludge disintegration by investigating multiple electrochemical pretreatment conditions: Performance, mechanism and modeling Journal article
Qingshan Lin, Xinlei Dong, Shihao Xi, Boyi Cheng, Feixiang Zan, Jie Ma, Xiaoming Liu, Tianwei Hao, Gang Guo. Optimizing waste activated sludge disintegration by investigating multiple electrochemical pretreatment conditions: Performance, mechanism and modeling[J]. Science of the Total Environment, 2023, 870, 162025.
Authors:  Qingshan Lin;  Xinlei Dong;  Shihao Xi;  Boyi Cheng;  Feixiang Zan; et al.
Favorite | TC[WOS]:5 TC[Scopus]:6  IF:8.2/8.6 | Submit date:2023/02/28
Cost-effectiveness  Electrochemical Pretreatment  Reactive Chlorine Species  Waste Activated Sludge Disintegration  
Long-Term Cost-Effectiveness of Subcutaneous Once-Weekly Semaglutide Versus Polyethylene Glycol Loxenatide for Treatment of Type 2 Diabetes Mellitus in China Journal article
Liu, Lei, Ruan, Zhen, Ung, Carolina Oi Lam, Zhang, Yawen, Shen, Yang, Han, Sheng, Jia, Ruxu, Qiao, Jingtao, Hu, Hao, Guo, Lixin. Long-Term Cost-Effectiveness of Subcutaneous Once-Weekly Semaglutide Versus Polyethylene Glycol Loxenatide for Treatment of Type 2 Diabetes Mellitus in China[J]. Diabetes Therapy, 2023, 14(1), 93-107.
Authors:  Liu, Lei;  Ruan, Zhen;  Ung, Carolina Oi Lam;  Zhang, Yawen;  Shen, Yang; et al.
Favorite | TC[WOS]:6 TC[Scopus]:8  IF:2.8/2.9 | Submit date:2023/01/08
Cost-effectiveness Analysis  Type 2 Diabetes  Glucagon-like Peptide-1 Analogue  Semaglutide  Peg-loxenatide  China  
The cost-effectiveness analysis of analgesic treatment options for postoperative pain following laparotomy surgeries Journal article
Xie, Han, Chen, Si Huang, Li, Li, Ge, Wei Hong. The cost-effectiveness analysis of analgesic treatment options for postoperative pain following laparotomy surgeries[J]. International Journal of Clinical Pharmacy, 2022.
Authors:  Xie, Han;  Chen, Si Huang;  Li, Li;  Ge, Wei Hong
Favorite | TC[WOS]:2 TC[Scopus]:3  IF:2.6/2.4 | Submit date:2023/01/30
Cost-effectiveness Analysis  Dezocine  Flurbiprofen  Patient-controlled Analgesia  Postoperative Pain  
Long-Term Cost-Effectiveness Analysis of Once-Weekly Semaglutide versus Dulaglutide in Patients with Type 2 Diabetes with Inadequate Glycemic Control in China Journal article
Ruan, Zhen, Ung, Carolina Oi Lam, Shen, Yang, Zhang, Yawen, Wang, Weihao, Luo, Jingyi, Zou, Huimin, Xue, Yan, Wang, Yao, Hu, Hao, Guo, Lixin. Long-Term Cost-Effectiveness Analysis of Once-Weekly Semaglutide versus Dulaglutide in Patients with Type 2 Diabetes with Inadequate Glycemic Control in China[J]. DIABETES THERAPY, 2022, 13(10), 1737-1753.
Authors:  Ruan, Zhen;  Ung, Carolina Oi Lam;  Shen, Yang;  Zhang, Yawen;  Wang, Weihao; et al.
Favorite | TC[WOS]:5 TC[Scopus]:8  IF:2.8/2.9 | Submit date:2022/08/28
China  Cost-effectiveness  Diabetes  Dulaglutide  Semaglutide  
Exploring the implementation of an outreach specialist program for nursing home residents in Macao: A multisite, qualitative study Journal article
Cen, Zhifeng, Li, Junlei, Hu, Hao, Lei, Ka Cheng, Loi, Cheng I, Liang, Zuanji, Chan, Tek Fai, Ung, Carolina Oi Lam. Exploring the implementation of an outreach specialist program for nursing home residents in Macao: A multisite, qualitative study[J]. Frontiers in Public Health, 2022, 10, 950704.
Authors:  Cen, Zhifeng;  Li, Junlei;  Hu, Hao;  Lei, Ka Cheng;  Loi, Cheng I; et al.
Favorite | TC[WOS]:1 TC[Scopus]:1  IF:3.0/3.6 | Submit date:2023/01/08
Nursing Home  Public-private Partnership  Macao  Outreach Specialist Program  Inter-disciplinary  Elderly  Patient-centered Care  Cost-effectiveness  
Efficacy, safety, and cost-effectiveness analysis of aflibercept in metastatic colorectal cancer: A rapid health technology assessment Review article
2022
Authors:  Ge, Pu;  Wan, Ning;  Han, Xiao;  Wang, Xinpei;  Zhang, Jinzi; et al.
Favorite | TC[WOS]:2 TC[Scopus]:1  IF:4.4/5.0 | Submit date:2023/01/30
Aflibercept  Cost-effectiveness Analysis  Metastatic Colorectal Cancer  Pharmacoeconomics  Rapid Health Technology Assessment  Targeted Drugs  
Atezolizumab plus platinum-based chemotherapy as first-line therapy for metastatic urothelial cancer: A cost-effectiveness analysis Journal article
Liu, Xiaoyan, Lang, Yitian, Chai, Qingqing, Lin, Yan, Liao, Yahui, Zhu, Yizhun. Atezolizumab plus platinum-based chemotherapy as first-line therapy for metastatic urothelial cancer: A cost-effectiveness analysis[J]. Frontiers in Pharmacology, 2022, 13.
Authors:  Liu, Xiaoyan;  Lang, Yitian;  Chai, Qingqing;  Lin, Yan;  Liao, Yahui; et al.
Favorite | TC[WOS]:4 TC[Scopus]:4  IF:4.4/5.0 | Submit date:2023/01/30
Atezolizumab  Cost-effectiveness  Metastatic Urothelial Cancer  Partitioned Survival Model  The Perspective Of The United States And China  
Pharmacoeconomic evaluation of dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes mellitus: a systematic literature review Review article
2022
Authors:  Ruan, Zhen;  Zou, Huimin;  Lei, Qing;  Ung, Carolina Oi Lam;  Shi, Honghao; et al.
Favorite | TC[WOS]:3 TC[Scopus]:3  IF:1.8/2.2 | Submit date:2022/05/17
Cost-effectiveness  Dipeptidyl Peptidase-4 Inhibitors  Dpp-4i  Pharmacoeconomic  Systematic Review  Type 2 Diabetes Mellitus